Amneal Pharmaceuticals, Inc. (AMRX)
14.52
-0.25
(-1.69%)
USD |
NASDAQ |
Feb 06, 16:00
14.52
0.00 (0.00%)
After-Hours: 20:00
Amneal Pharmaceuticals SG&A Expense (TTM) : 509.06M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Pfizer Inc. | 13.79B |
| Corcept Therapeutics, Inc. | 401.86M |
| Merck & Co., Inc. | 10.73B |
| Apellis Pharmaceuticals, Inc. | 524.64M |
| Nektar Therapeutics | 74.62M |